PREVNAR 13 Wyeth
Blood & Organ Banks · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.prevnar.caRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PREVNAR 13 Wyeth
Prevnar® 13 is a pneumococcal vaccine that helps protect children, adolescents and adults 18 years and older against serious diseases such as meningitis, bacteraemia, sepsis (bacteria in bloodstream) and bacteraemic pneumonia caused by 13 types of Streptococcus pneumoniae bacteria.Explore more
Popular SearchesPREVNAR 13 Wyeth LLCSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PREVNAR 13 Wyeth your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when PREVNAR 13 Wyeth launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PREVNAR 13 Wyeth had a recent Job posting/layoffs
PREVNAR 13 Wyeth, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if PREVNAR 13 Wyeth is spiking on competitors!
Check if PREVNAR 13 Wyeth has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at PREVNAR 13 Wyeth
Funding: Get notified immidiatlly once PREVNAR 13 Wyeth has new funding data
Earning: See what the market has to say on PREVNAR 13 Wyeth recently announced quarterly report
Recommended Actions
Find VP level buyers at PREVNAR 13 Wyeth
Find 2 more new buyers
Compare Similar Companies to PREVNAR 13 Wyeth
Compare insights from companies similar to PREVNAR 13 Wyeth, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PREVNAR 13 Wyeth
<$5M
1-10
Private
-
-
N/A
PREVNAR 13 Wyeth Tech Stack
A closer look at the technologies used by PREVNAR 13 Wyeth
See more technologies
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding PREVNAR 13 Wyeth
Sign Up For FreeTo access detailed company insights
Prevnar® 13 is a pneumococcal vaccine that helps protect children, adolescents and adults 18 years and older against serious diseases such as meningitis, bacteraemia, sepsis (bacteria in bloodstream) and bacteraemic pneumonia caused by 13 types of Streptococcus pneumoniae bacteria.... Read More
